NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
University Hospital, Lille
Delfi Diagnostics Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Medipol University
University Hospital Padova
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Thomas Jefferson University
Revolution Medicines, Inc.
The Cleveland Clinic
University Medical Center Groningen
University Medical Center Groningen
Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares
Weill Medical College of Cornell University
St. Antonius Hospital
Erasca, Inc.
Revolution Medicines, Inc.
University of Wisconsin, Madison
H. Lee Moffitt Cancer Center and Research Institute
Syndax Pharmaceuticals
Syndax Pharmaceuticals
University Hospital, Tours
Beni-Suef University
H. Lee Moffitt Cancer Center and Research Institute
ChineseAMS
Shanghai Pulmonary Hospital, Shanghai, China
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Washington
AVEO Pharmaceuticals, Inc.
University Hospital, Rouen